FDA schedules meeting on stats guidance for late July, in Rockville:
This article was originally published in Clinica
The US FDA has scheduled a public meeting to discuss its new draft guidance on how to use Bayesian statistics in the design and analysis of medical device clinical trials. The meeting will take place on July 27, at the Universities of Shady Grove in Rockville, Maryland. For more information, contact Bridgette Stein in the device centre's (CDRH) division of biostatistics, on tel: +1 240 276 4146.